Health ❯ Diseases ❯ Blood Disorders

Sickle Cell Disease

Patient Experiences Casgevy Gene Therapies Treatment Prevalence Future Treatments Gene Therapy Access to Treatment Lyfgenia Cure Options

NYU Study Finds Highest Sickle Cell Death Risk and Costs on Long Island

The findings point to gaps in specialist access on Long Island.

Agios’ Sickle Cell Pill Lifts Hemoglobin but Misses Pain-Crisis Goal in Phase 3

Breakthrough Gene Therapies Offer New Hope for Sickle Cell Disease

FDA Approves Vertex/CRISPR Gene Therapy for Beta Thalassemia

Sickle Cell Gene Therapies Unreachable for Most Affected Countries

FDA Approves First-Ever CRISPR Gene-Editing Treatment for Sickle Cell Disease